Oncostatin M Receptor anticorps
Aperçu rapide pour Oncostatin M Receptor anticorps (ABIN7117115)
Antigène
Voir toutes Oncostatin M Receptor (OSMR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- OSMR antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- oncostatin M receptor
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- Oncostatin M Receptor (OSMR)
-
Autre désignation
- OSMR
-
Sujet
-
Synonyms: Oncostatin-M-specific receptor subunit beta|Interleukin-31 receptor subunit beta (IL-31 receptor subunit beta, IL-31R subunit beta, IL-31R-beta, IL-31RB)|OSMR|OSMRB
Background: Associates with IL31RA to form the IL31 receptor. Binds IL31 to activate STAT3 and possibly STAT1 and STAT5. Capable of transducing OSM-specific signaling events.
-
ID gène
- 9180
-
UniProt
- Q99650
-
Pathways
- Signalistation JAK/STAT, Growth Factor Binding
Antigène
-